With Forzinity, US FDA Accelerated Approval Still Can Precede Confirmatory Trial Enrollment

 
• By Sue Sutter
  
First and second priority
The FDA prioritized drug access over confirmatory trial initiation in its accelerated approval of Forzinity. (Shutterstock)

More from Drug Review Profiles

More from United States